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Abstract
The ability to measure oxygen partial pressure (pO2) with high temporal and spatial resolution in 
three dimensions is crucial for understanding oxygen delivery and consumption in normal and 
diseased brain. Among existing pO2 measurement methods, phosphorescence quenching is 
optimally suited for the task. However, previous attempts to couple phosphorescence with two-
photon laser scanning microscopy have faced substantial difficulties because of extremely low 
two-photon absorption cross-sections of conventional phosphorescent probes. Here, we report the 
first practical in vivo two-photon high-resolution pO2 measurements in small rodents’ cortical 
microvasculature and tissue, made possible by combining an optimized imaging system with a 
two-photon-enhanced phosphorescent nanoprobe. The method features a measurement depth of up 
to 250 µm, sub-second temporal resolution and requires low probe concentration. Most 
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importantly, the properties of the probe allowed for the first direct high-resolution measurement of 
cortical extravascular (tissue) pO2, opening numerous possibilities for functional metabolic brain 
studies.
INTRODUCTION
The functioning of the brain is critically dependent on oxygen supply.1–3 Previous 
measurements indicate great variability in both vascular and tissue pO24–7 that is likely to 
arise from variations in blood flow and metabolic demand in different regions of the brain. 
However, the precise mechanisms of the regulation of the oxygen supply are still largely 
unknown,8 in part because of an inability to accurately and rapidly measure cortical vascular 
and tissue pO2 at increased depth with high resolution. The existing oxygen measurement 
methods (e.g., electrodes,7 binding of nitroimidazole-based drugs,9 electron paramagnetic 
resonance methods,10, 11 hemoglobin optical absorption-based methods12–14) suffer from 
either low sensitivity or low spatial or temporal resolution, or are invasive by nature. Among 
optical approaches, oxygen-dependent quenching of phosphorescence15 stands out in its 
ability to provide fast absolute measurements of pO2, which are unaffected by changes in 
optical properties of the tissue. Previous studies have applied phosphorescence quenching to 
image oxygen in a variety of biological tissues,16–20 including examples of microscopy.21
The combination of phosphorescence quenching with two-photon microscopy22 is a natural 
synergy since two-photon excitation, which is characterized by a high degree of spatial 
confinement and a reduced risk of photodamage, should allow pO2 measurements deeper in 
the brain with high resolution. Unfortunately, direct coupling of phosphorescence with two-
photon microscopy is hampered by extremely low two-photon absorption cross-sections of 
phosphorescent probes, necessitating very high excitation powers, long acquisition periods 
and/or exceedingly high probe concentrations.23, 24 Here we show that, by using a specially 
designed two-photon-enhanced phosphorescent nanoprobe PtP-C34325 and an optimized 
microscopy setup, this limitation can be overcome, allowing for pO2 measurements in 
capillaries down to 240 µm below the brain surface with high (~0.5 s per point) temporal 
resolution. Importantly, the signal in these measurements is phosphorescence lifetime, not 
intensity, and thus it is independent of the local probe concentration. We report an extensive 
map of intravascular pO2 values as they vary from the pial arteries through the capillary 
network into the draining veins. Furthermore, the unique properties of the probe allowed for 
the first direct high-resolution measurements of cortical tissue pO2 in vivo down to 100 µm 
below the brain surface. We demonstrated the functionality of this method by measuring 
spatio-temporal variations in tissue pO2 arising from hypoxia and by simultaneously 
measuring intravascular and tissue (extravascular) pO2.
RESULTS
Two-photon-enhanced phosphorescent probe PtP-C343
PtP-C34325 (Supplementary Fig. 3), belongs to the family of dendritically protected 
phosphorescent probes.26 Its core is formed by a highly phosphorescent Pt porphyrin (PtP), 
encapsulated inside poly(arylglycine) dendrimer. The dendrimer protects the porphyrin from 
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interaction with components of the measurement system and controls the rate of oxygen 
quenching. Several coumarin-343 (C343) units, attached at the periphery of the dendrimer, 
capture two-photon excitation energy and transfer it non-radiatively to the porphyrin. Upon 
excitation, PtP undergoes fast intersystem crossing into its triplet state and emits 
phosphorescence, which is quenched by molecular oxygen in a diffusion-controlled manner. 
The lifetime of the phosphorescence decay (typically several tens of microseconds) is 
inversely proportional to the pO2 (via Stern-Volmer relationship), thus forming the signal 
for analytical pO2 determination.
The remaining termini on the dendrimer in PtP-C343 are modified with polyethyleneglycol 
(PEG) residues. PEGylation ensures that the probe's signal is insensitive to proteins and 
other macromolecular solutes in biological systems. Dendritic porphyrin-based dyes used 
earlier could operate only when bound to albumin in the blood. However, at higher 
concentrations (above ~10−5 M), a significant fraction of these probes remain unbound, 
causing phosphorescence decays to become poorly interpretable and pO2 measurements 
irreproducible and inaccurate. PEGylated probes do not require binding to albumin for 
measurements in the physiological oxygen range and, if required, can be used at very high 
concentrations without causing ambiguity in pO2 determination. The probe used in this 
study was modified with polyethyleneglycol residues of average Molecular Weight (Av. 
MW) 2,000, as opposed to shorter polyethyleneglycols (Av. MW 750), used in the original 
molecule.25 This rendered the probe less aggregated and increased its signal dynamic range.
Experimental setup
For two-photon in vivo brain imaging we constructed a microscope with high signal 
collection efficiency and photon-counting detection (Fig. 1). We performed imaging on the 
brain of anesthetized animals through sealed cranial windows, either injecting the 
phosphorescence probe into the vasculature through the femoral artery or pressure-injecting 
it directly into the brain tissue. We obtained structural images of the cortical vasculature by 
imaging intravenously administered fluorescein-dextran. We excited phosphorescence by 
trains of femtosecond pulses from a Ti:Sapphire oscillator, gated by an electro-optic 
modulator, and acquired decays by averaging multiple excitation cycles. Each cycle 
consisted of a 20–80 µs excitation gate, followed by 300-µs collection period, using an 
average laser power during the excitation gate of ~10 mW at the laser focus. We estimate 
that under this excitation regime the emitting volume had ~2 µm lateral (XY) and ~5 µm 
axial (Z) dimensions. This increase in the excitation volume, compared to its true 
diffraction-limited size, was caused by saturation effects.25 Nevertheless, these dimensions 
still permitted sufficient spatial resolution, while allowing for a much stronger signal and 
therefore a faster temporal response.
In a typical experiment, we performed detection in two steps. First, we raster-scanned the 
excitation beam over the field of view, rendering two-dimensional survey maps of the 
integrated emission intensity (250 × 250 pixels, acquired in ~25 s). An example of such a 
single-plane scan performed 166 µm below the brain surface (Fig. 1c), demonstrates the 
ability of the system to resolve the structure of the microvasculature down to the capillary 
level. After mapping the tissue, we averaged 500–2,000 phosphorescence decays in selected 
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locations within the vasculature for accurate pO2 determination (Fig. 1d). This acquisition 
time corresponded to a temporal resolution of 0.16–0.76 s per single-point pO2 
measurement, while the measurement of the entire vasculature stack required up to 30 min. 
Finally, using Stern-Volmer calibration plots, we converted phosphorescence lifetimes, 
obtained by fitting, into pO2 values.
Oxygen tension in cortical microvasculature
In a typical experiment we measured approximately 100 pO2 values in 30-µm steps down to 
240 µm below the cortical surface in the mouse brain (Fig. 2a). The obtained pO2 values 
agreed well with previously published measurements in small rodent cortices.5, 7 We were 
able to directly measure pO2 in capillaries (Fig. 2b and Supplementary Fig. 1) and in 
consecutive vascular branches. Starting from the pial arteriole (Fig. 2b), pO2 values decrease 
to 61.1 mmHg, 61.8 mmHg, 48.2 mmHg, 42.8 mmHg, and 29.7 mmHg along the 
descending vessels down to the capillary level, at a depth of 240 µm.
We generally observed a decrease in the vascular pO2 with an increase in the cortical depth 
(Fig. 2c). The average pO2 (measured in three animals; excluding pial arterioles) decreased 
by ~10 mmHg moving from the pial veins down to a depth of ~240 µm. This observation 
supported previous findings6, 27 showing a relatively rapid initial decrease of tissue pO2 
with cortical depth. Interestingly, we also observed an average pO2 increase of ~7 mmHg 
towards the cortical surface in the three ascending venules (Fig. 2c), which drain blood from 
the deeper cortical layers, suggesting the possibility of oxygen efflux from the tissue into the 
venous compartment. A recent report makes a similar observation using the measurement of 
hemoglobin saturation as a vascular pO2 indicator.28
Oxygen tension in cortical tissue and microvasculature
To perform tissue pO2 measurement, we injected PtP-C343 directly into the interstitial 
space. Based on the phosphorescence intensity measurements, the concentration of PtP-
C343 in the tissue in these experiments was comparable to or lower than that used in 
vascular measurements. Importantly, two-photon excitation made it possible to confine the 
phosphorescence quenching by oxygen to the immediate vicinity of the focal plane, thus 
minimizing oxygen consumption and/or phototoxicity. Other studies show that oxygen 
consumption can skew tissue pO2 measurements at high excitation intensities.21 In our 
experiments, we could not observe any changes in the phosphorescence lifetime when 
performing multiple repetitive measurements at the same location.
We measured tissue pO2 values (Fig. 3) during normoxia in a rat in 29 locations ~100 µm 
below the cortical surface (Fig. 3c). The obtained values (6–25 mm Hg) were within the 
range of the previously established cortical tissue pO2 levels.5–7 We observed relatively 
high pO2 values (> 20 mmHg) close to a large pial artery (points 6–9), and a relatively steep 
pO2 decay at locations farther away from the artery (points 10–13). These results are in 
agreement with the existence of tissue pO2 gradients at the cortical surface.5–7
Two-photon phosphorescence lifetime measurements have the unique capability of 
simultaneous monitoring of tissue pO2 at multiple locations at variable depths, making it 
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possible to conduct functional studies of the brain during transient changes in oxygenation. 
We acquired temporal pO2 profiles at selected locations (Fig. 3b) during hypoxia, created by 
30-s respiratory arrest (Fig. 3d–f). We averaged 500 decays in each location every 8.2 s, 
requiring 0.19 s per measurement and we cycled the scan sequence for the duration of the 
experiment through all selected locations. We grouped the locations according to their 
distances from the artery. During hypoxia, oxygen rapidly depleted in all of the measured 
locations; however, we observed a clear correlation between the locations and the character 
of the temporal profiles. Thus, closer to the artery (Fig. 3e) pO2 decreased more slowly and 
recovered more quickly upon return to normal breathing; whereas in most locations farther 
away from the artery (Fig. 3d,f), pO2 decreased faster and recovered more slowly.
We introduced the probe into both the vasculature and the interstitial space in order to 
perform concurrent pO2 measurement in these two compartments. We obtained maps of pO2 
values measured at several locations around and inside diving venules and ascending 
arterioles in the rat cortex (Fig. 4). A map of more than 500 locations (Fig. 4a) shows high 
pO2 values inside and elevated pO2 values around the diving arteriole. In contrast, we 
observed only slightly elevated intravascular pO2 in the ascending venule with respect to the 
surrounding tissue pO2. In a grid of pO2 measurements (Fig. 4b), covering the area of an 
ascending venule and branches of a small descending arteriole, slightly higher pO2 values 
are evident in the venule with respect to the surrounding tissue pO2. In addition, we noted an 
elevated tissue pO2 in the vicinity of the arterial branches.
DISCUSSION
Oxygen is a key metabolite, and tissue oxygenation is one of the most critical parameters 
with respect to brain physiology and pathology. Nevertheless, imaging technologies for 
mapping brain oxygenation, especially at the microscopic level, are only beginning to be 
developed. The developed technique opens up numerous possibilities for metabolic studies 
in neuroscience that will advance our understanding of brain metabolism and function under 
normal and pathological conditions.
With respect to brain studies, the key advantages of the two-photon phosphorescence 
quenching technique are its minimal invasiveness and the possibility of achieving high 
temporal and spatial resolution at substantial cortical depths. The probe's signal is 
independent of pH throughout the physiological range and is not affected by the presence of 
biological macromolecules.25 Due to its relatively large molecular size (~3–4 nm in the 
folded state), PtP-C343 is characterized by a long half life (~2 h) in the circulation 
(Supplementary Fig. 2). We did not detect any leakage of the probe from the vasculature 
into the interstitial space in the brain. A convenient feature of the method is its absolute 
calibration, i.e. the probe constants need to be measured only once and do not require 
repetitive calibrations. Moreover, because the quenching reaction is independent of the 
pathway by which the probe is converted to its triplet state, calibration plots 
(phosphorescence lifetime τ dependence on pO2) are expected to be identical for single- and 
two-photon excitation. Indeed, calibration of PtP-C343 confirmed that with a properly 
selected excitation regime, Stern-Volmer plots obtained in vivo in the blood using the two-
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photon microscopy setup were the same as measured in a regular titration experiment using 
linear excitation (see Methods, and Supplementary Figs. 2 and 3, for details).
It is important to keep in mind that in all quenching-based oximetry methods most of the 
photodamage occurs due to the products of the quenching reaction (singlet oxygen and other 
reactive oxygen species). Thus, it is necessary to optimize probe concentration/excitation 
regime in order to minimize undesirable phototoxic effects. Two-photon excitation makes it 
possible to avoid formation of toxic species everywhere along the excitation path, and to 
confine it to the immediate vicinity of the laser focus. As a result, singlet oxygen generation 
in our experiments was minimized. We performed tests of cell viability using apoptosis and 
neuronal degeneration sensitive stainings 24 h after measuring tissue pO2 in a dense grid 
pattern (Supplementary Fig. 4). In all cases, there was no evidence of phototoxicity.
Until now, the lack of technologies for direct 3D mapping of oxygen availability in the brain 
has been a major limiting factor in investigations of oxygen metabolism. Simultaneous 
imaging of intravascular pO2 and tissue pO2 gradients will allow direct measurement of 
oxygen extraction fraction and, when combined with measures of blood flow,29 the cerebral 
metabolic rate of oxygen, the central parameters for interpretation of blood oxygenation 
level dependent (BOLD) functional magnetic resonance imaging (fMRI).1 Furthermore, this 
methodology can be directly applied in other areas, such as stroke, cancer, neurological 
conditions, and heart failure, where accurate non-invasive determination of pO2 is the key to 
understanding physiological function. The synergism of two-photon phosphorescent 
measurements with other two-photon microscopy tools for imaging of neuronal, vascular 
and metabolic activity opens the door to a more integrative approach for addressing critical 
questions regarding the order of pathological events in the progression of disease and 
promises to provide an objective way for screening of potential therapies.
METHODS
Imaging setup
We used a custom-built microscope setup in this study (Fig. 1a). The system was controlled 
by custom-designed software written in LabView (National Instruments). The optical beam 
was scanned in the XY plane by galvanometer scanners (6215H, Cambridge Technology, 
Inc.) and focused on the sample by an objective (Olympus 20X XLumPlanFL; NA=0.95). A 
motorized stage controlled the focal position along the vertical axis (Z), and an electro-optic 
modulator (ConOptics, Inc., extinction ratio ~500) served to gate the output of a Ti:Sapphire 
oscillator (840 nm, 80 MHz, 110 fs, Mai-Tai, Spectra-Physics). The maximal laser power on 
the object during excitation gate was ~90 mW when imaging at large cortical depths and 10–
20 mW at the surface. Increases in the power were necessary when working at higher depth 
to compensate for scattering and to maintain approximately 10 mW power in the focal plane. 
The pulse duration was ~350 fs (assuming sech2 pulse shape), as measured at the sample. 
The emission was reflected by a dichroic mirror (LP 735 nm, Semrock) and detected by a 
detector array, consisting of four independent photomultiplier tubes (PMTs), with a large 
collection efficiency (~15 mm2 sr). The phosphorescence output was passed through a 680 ± 
30 nm band-pass filter and forwarded to a photon-counting PMT module (H10770PA-50, 
Hamamatsu), whose output was acquired by a 50 MHz digital board (NI PCle-6537, 
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National Instruments) and saved for later processing. In order to determine the 
phosphorescnece lifetime, we fitted the phosphorescence intensity decay with a single-
exponential function using the non-linear least-squares method. The lifetime was converted 
to pO2 using the calibration plot obtained in independent oxygen titration experiments25 
(Supplementary Fig. 2).
Animal preparation
For imaging of pO2 in the microvasculature, we anesthetized CD-1 mice (male, 25–30 g, 
10–12 weeks old) by isoflurane (1–2% in a mixture of O2 and N2O) under constant 
temperature. We then opened a cranial window in the parietal bone with intact dura and 
sealed it with a 150-µm-thick microscope coverslip. During the experiments, we used a 
catheter in the femoral artery to monitor the blood pressure (75–85 mmHg) and blood gases 
(pCO2: 36–39 mmHg, and pO2: 110–160 mmHg) and to administer the dyes. The 
concentration of PtP-C343 in the blood immediately after administration was ~16 µM. 
During the measurement period mice breathed a mixture of O2 and air under the same 
isoflurane anesthesia.
For measurements of pO2 in tissue (interstitial space), Sprague Dawley rats (250–320 g) 
were temperature controlled, anesthetized with isofluorane (1.5–2% in a mixture of O2 and 
air) and tracheotomized, and catheters inserted in the femoral artery and vein for 
administering the anesthesia and dyes and for measuring blood gases and blood pressure. 
We created a sealed cranial window in the center of the parietal bone with the dura removed. 
Before sealing the window, we pressure-injected ~0.1 µL of PtP-C343 (1.4×10−4 M) with 
the micropipette ~300 µm below the surface of the brain. We performed imaging a few 
hundred microns from the injection site. The probe spreading in the brain tissue appears to 
have been sufficiently slow to allow imaging of pO2 for several hours following the 
injection. During the measurements, we ventilated rats with a mixture of air and O2. 
Isofluorane was discontinued and anesthesia maintained with a 50 mg/kg intravenous bolus 
of alpha-chloralose followed by continuous intravenous infusion at 40 mg/(kg h). In the 
resting condition the systemic arterial blood pressure was 95–110 mmHg, pCO2 was 35–44 
mmHg, and pO2 was 95–110 mmHg. We created hypoxic conditions by stopping the 
respirator for 30 s. We administrated intravenous bolus of Pancuronium Bromide (2 mg/kg) 
followed by continuous intravenous infusion at 2 mg/(kg h) during the breath-hold 
experiment to minimize possible animal motion. In all measurements, we compared the 
phosphorescence survey scans taken immediately before and after pO2 point measurements 
and inspected collected phosphorescence decays for signs of sudden intensity or decay slope 
change during acquisition, which could indicate motion artifact during the measurement. For 
simultaneous intravascular and tissue pO2 measurements, we used Sprague Dawley rats (90–
120 g, 7 animals), applying the same surgical procedure. We adjusted intravascular 
concentration of the probe (10–30 µM) in each animal to obtain satisfactory visibility in 
phosphorescence survey images. While animal preparations with tracheotomized rats allow 
generally longer and better controlled experiments, the choice of mice and small rats was 
motivated by a need to limit the amount of probe used in the experiments involving 
intravascular pO2 measurements. All experimental procedures were approved by the 
Massachusetts General Hospital Sub-committee on Research Animal Care.
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Construction of the composite images
We obtained structural images of the cortical vasculature following the pO2 measurements 
by labeling the blood plasma with Dextran-conjugated fluorescein (FITC, FD2000S, Sigma) 
and performing two-photon fluorescence imaging. We subsequently created a graph of the 
vascular network using a previously established procedure.30 We performed image 
processing and data analysis using custom-designed software in Matlab (MathWorks), code 
is available from the authors upon request. The locations in which oxygen tension were 
measured were co-registered with this image, and three-dimensional composite images were 
created with both vasculature structure (shades of gray) and color-coded measured pO2 
values. We color-coded the latter by assigning a pO2 value either to the whole vessel 
segment between two branching points, or to the neighboring portion of the vessel segment 
if more than one pO2 measurement was performed in that segment. In addition, in some 
cases (Fig. 2b), for segments that did not have a measurement but joined at both ends with 
segments that had measurements within 100 µm, we assigned the average pO2 value of the 
connecting segments. Although not quantitative, this procedure allowed more complete 
visualization of the vascular tree. In the future, simultaneous measurement of pO2 and blood 
flow in the microvasculature29 will greatly improve the accuracy of pO2 estimation in the 
remaining parts of the vascular tree.
PtP-C343 synthesis and spectroscopy
General—We obtained all solvents and reagents from commercial sources and used as 
received. We obtained PEG-amine (Av. MW 2,000) from Laysan Bio. Inc. We synthesized 
PtP-(AG3OH)4(C343)5 as described previously.25, 31 We performed preparative GPC on S-
X1 (Biorad) beads, using THF as a mobile phase. The system for oxygen titrations was 
described previously.32, 33 We performed time-resolved phosphorescence measurements 
using a phosphorometer constructed in-house,34 modified for time-domain operation.
Synthesis of the PtP-C343 modified with PEG-amines (Av. MW 2,000)—
Carboxy-terminated porphyrin-dendrimer PtP(AG3OH)4(C343)5 (107 mg, 0.012 mmol) was 
dissolved in DMF (10 ml). We heated the mixture for several minutes (~5–10 min) with a 
heat gun in the dark under argon flow and then allowed it to cool down to the room 
temperature. Stirring continued until the dendrimer appeared fully dissolved. We added 
HBTU (182 mg, 0.48 mmol) in one portion and stirred the mixture for 5 min. We added 
DIPEA (0.146 ml, 0.84 mmol) in one portion by a syringe, immediately followed by the 
addition of mPEG-NH2, Av. MW 2,000 (960 mg, 0.48 mmol) in DMF (5 ml). The mixture 
was protected from ambient light and left stirring for 2 days.
We added ether (~30 ml) to the reaction mixture, leading to the formation of brightly 
colored oil while leaving the mother liquor colorless. The oil was separated by 
centrifugation, dissolved in THF, separated again by the addition of ether and centrifugation. 
This procedure was repeated two more times to remove most of the unreacted amino-PEG. 
We achieved the final purification by size-exclusion chromatography using THF as a 
solvent. The brown band was collected, the solvent was removed by rotary evaporation and 
the probe was briefly dried in vacuum. We dissolved this in a small amount of distilled 
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water (~5 ml), filtered it through a PTFE syringe filter (0.2 µm pore diameter), and freeze-
dried it on a lyophilizer. The probe was isolated as brown solid material (yield: 86%).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Phosphorescence detection procedure
(a) Experimental setup. PC1 and PC2 – computers, SH – shutter, EOM – electro-optic 
modulator, GS – galvanometer scanner. (b) Maximum intensity projection (MIP) along z 
direction of a 250 µm thick stack in the mouse cortex. The vasculature was labeled with 
FITC. (c) Phosphorescence intensity image of microvasculature obtained at 166 µm depth 
below the cortical surface. The color bar shows the average number of counts in each pixel 
collected during single phosphorescence decay. Scale bar, 100 µm. (d) Experimental 
measurement (dots) and corresponding single exponential fits (solid lines) of two 
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phosphorescence decays from the diving arteriole (A, red) and ascending venule (V, blue), 
with positions marked with the arrows in (b) and (c).
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Figure 2. Measurement of pO2 in cortical microvasculature
(a) Measured pO2 values in microvasculature at various depths, overlaid on the MIP image 
of the vasculature structure (grey). Digital processing was performed to remove images of 
the dura vessels. For easier identification, the edges of the major pial arterioles and venules 
were outlined in red and blue, respectively. Scale bar, 200 µm. (b) Composite image 
showing a projection of the imaged vasculature stack. Four pO2 measurement locations in 
the capillary vessels at 240 µm depth are marked with red arrows. Five orange arrows point 
to the consecutive branches of the vascular tree, from pial arteriole (arrow at left) to the 
capillary level and further to the connection with ascending venule (arrow at upper right). 
Scale bar, 200 µm. (c) The pO2 dependence with cortical depth in three mice averaged 
across all vessels excluding pial arterioles. Dotted black line shows average pO2 dependence 
with cortical depth in three ascending venules, at positions outlined with the circles in (a). 
The error bars represent standard error at each depth. Composite image in the corner shows 
a side projection of the two circled ascending venules from the upper right corner in (a). 
These ascending venules are marked with black arrows in (c).
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Figure 3. Measurement of pO2 in cortical tissue
(a) Volumetric image of the 200 µm-thick FITC-labeled microvasculature stack in the rat 
cortex. A large pial artery (red, marked with arrows in (a) and (b)) and two pial veins (blue) 
are color-coded for easier identification. (b) An integrated phosphorescence intensity image 
at 100 µm depth. Grey bar represents average number of counts from single 
phosphorescence decay at each pixel. Scale bar, 200 µm. (c) Measured pO2 values during 
normoxia are overlaid with the grey-scale microvasculature structural image at 100 µm 
depth. (d)–(f) Temporal profiles of the measured pO2 values at selected locations (b) during 
hypoxia. The period of the hypoxia is indicated by the grey bar.
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Figure 4. Simultaneous measurement of pO2 in cortical vasculature and tissue
(a) Measured pO2 values overlaid with the grey scale phosphorescence intensity image at 40 
µm depth. Measurements were performed at locations of descending arteriole (left) and 
ascending venule (right). Measurement locations were also marked with the white rectangles 
in the inset (top left), which shows a MIP of 80 µm-thick FITC-labeled microvasculature 
stack. Artery (red) and vein (blue) are color-coded for easier identification. Scale bars, 100 
µm. (b) Measured pO2 values overlaid with the grey scale phosphorescence intensity image 
at 60 µm depth. Measurements were performed at the location of an ascending venule. 
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Measurement location is marked with the white rectangle in the inset (bottom right), 
showing MIP of 80 µm-thick FITC-labeled microvasculature stack. Ascending venule (blue) 
and branches of the descending arteriole (red) are color-coded for easier identification. Scale 
bars, 50 µm.
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